相关实验视频
Updated: Jun 25, 2025

05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.1K
斯皮诺辛通过增强Nrf2/HO-1信号通路来改善骨关节炎
Peipei Lu1, Shuxiang Li2, Caoyang Zhang3
1Nursing Department, Changzhou Hygiene Vocational Technology College, Changzhou. 1294495540@qq.com.
European journal of histochemistry : EJH
|May 23, 2024
概括
脊素 (SPI) 通过激活Nrf2通路来保护软骨,减少氧化应激和细胞的基质降解. 这种天然化合物通过保持关节健康来治疗骨关节炎 (OA) 是有前途的.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨关节炎 (OA) 是一种普遍存在的退行性关节疾病.
- 氧化应激和冠状细胞功能障碍是OA病变发生的关键驱动因素.
- 核因子红色素2相关因子2 (Nrf2) 是对氧化应激的关键细胞内防御,但其表达通常在OA红细胞中受到抑制.
研究的目的:
- 研究已知Nrf2激动剂Spinosin (SPI) 对氧化应激诱导的淋巴细胞退行变化的作用.
- 探索SPI作为治疗骨关节炎 (OA) 的治疗剂的潜力.
主要方法:
- 利用三丁氧化物 (TBHP) 诱导氧化应激和细胞外基质降解在细胞.
- 评估了通过SPI激活Nrf2,血红氧酶-1 (HO-1) 和NADPH子氧降解酶1 (NQO1) 的情况.
- 使用siRNA来沉默Nrf2表达,并评估其对SPI保护作用的影响.
- 在已建立的OA小鼠模型中测试了SPI的疗效.
主要成果:
- SPI缓解了冠状细胞中TBHP诱导的细胞外基质降解.
- 在氧化应激条件下,SPI显著激活了红细胞中的Nrf2,HO-1和NQO1.
- 沉默Nrf2降低了SPI的软骨保护作用.
- 在小鼠模型中,SPI显示了对OA的显著缓解作用.
结论:
- 脊素 (SPI) 通过改善氧化应激诱导的冠状细胞功能障碍,表现出冠状细胞保护作用.
- SPI激活Nrf2/HO-1通路,增强细胞防御机制,防止氧化损伤.
- SPI代表了骨关节炎治疗的有前途的治疗候选者.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K

